Literature DB >> 7416018

Kinetics of antifibrillatory effects of bretylium: correlation with myocardial drug concentrations.

J L Anderson, E Patterson, M Conlon, S Pasyk, B Pitt, B R Lucchesi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7416018     DOI： 10.1016/0002-9149(80)90507-x

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  10 in total

1.  Selective inhibition of K(+)-stimulation of Na,K-ATPase by bretylium.

Authors:  P E Tiku; P T Nowell
Journal:  Br J Pharmacol       Date:  1991-12       Impact factor: 8.739

2.  [Acute myocardial uptake of lidocaine, mexiletine and amiodarone].

Authors:  J Nitsch; J Leffler; B Lüderitz
Journal:  Klin Wochenschr       Date:  1990-07-05

3.  Potassium channel blockade: A mechanism for suppressing ventricular fibrillation.

Authors:  M B Bacaner; J R Clay; A Shrier; R M Brochu
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

Review 4.  Myocardial uptake of drugs and clinical effects.

Authors:  J D Horowitz; A C Powell
Journal:  Clin Pharmacokinet       Date:  1986 Sep-Oct       Impact factor: 6.447

Review 5.  New antiarrhythmic drugs: their place in therapy.

Authors:  D L Keefe; R E Kates; D C Harrison
Journal:  Drugs       Date:  1981-11       Impact factor: 9.546

6.  Pharmacological analysis of established ventricular fibrillation.

Authors:  E J Carlisle; J D Allen; W G Kernohan; W Leahey; A A Adgey
Journal:  Br J Pharmacol       Date:  1990-07       Impact factor: 8.739

Review 7.  Clinical pharmacokinetics of bretylium.

Authors:  W G Rapeport
Journal:  Clin Pharmacokinet       Date:  1985 May-Jun       Impact factor: 6.447

Review 8.  Pharmacokinetic and pharmacodynamic considerations in drug therapy of cardiac emergencies.

Authors:  P Pentel; N Benowitz
Journal:  Clin Pharmacokinet       Date:  1984 Jul-Aug       Impact factor: 6.447

9.  Pharmacokinetic-pharmacodynamic modelling of S(-)-atenolol in rats: reduction of isoprenaline-induced tachycardia as a continuous pharmacodynamic endpoint.

Authors:  T J van Steeg; J Freijer; M Danhof; E C M de Lange
Journal:  Br J Pharmacol       Date:  2007-04-10       Impact factor: 8.739

Review 10.  Sudden cardiac death and the potential role of beta-adrenoceptor-blocking drugs.

Authors:  I Rajman; M J Kendall
Journal:  Postgrad Med J       Date:  1993-12       Impact factor: 2.401
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.